Urowebinar: Strategies in urology to tackle antibiotic resistance

(50:51)

UROwebinar: Emerging strategies in tackling antimicrobial resistance in urology

(59:53)

Urowebinar: Treatment strategy in muscle invasive bladder cancer

(1:21)

UROWebinar: The history of prostate cancer screening trials: Lessons from ERSPC, PLCO and CAP

(1:1:47)

UROwebinar - Learn from the experts

(1:5)

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

(58:26)

UROwebinar: Ureteral stenosis and stones: The dog that chases its own tail

(1:11:16)

UROwebinar: Infections, antimicrobial stewardship and PCa detection: TP vs TRUS prostate biopsy

(1:1:24)

Urowebinar: Underactive bladder - The story so far

(56:54)

UROwebinar: How to overcome individual challenges in contemporary BPO management

(1:20)

UROwebinar: Renal, bladder and prostate cancer guidelines 2021: From guidelines to real world

(1:5:21)

UROWebinar: New technologies in urology, academics and research

(1:56)

Urowebinar: Minimally Invasive Treatment for Male LUTS

(1:2:28)

UROwebinar: Management of nmCRPC: Putting current evidence into practice

(51:5)

UROwebinar: Endourology: New technology and surgeon ergonomics (BASIS programme)

(1:28:46)

Urowebinar: Dealing with the challenge of infection in urology in the COVID era

(1:12:57)

UROwebinar: Difficult bladder cancer cases

(57:53)

Urowebinar: Practical management of bladder cancer

(1:1:32)

UROwebinar: Antimicrobial resistance in urogenital infections and how to manage?

(1:1:1econd)